Yu WD - Search Results

1

Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression.

Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, Egorin MJ, Trump DL, Johnson CS. Hershberger PA, et al. Among authors: yu wd. Mol Cancer Ther. 2002 Aug;1(10):821-9. Mol Cancer Ther. 2002. PMID: 12492115

2

Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.

Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS. Ma Y, et al. Among authors: yu wd. Cancer Res. 2006 Aug 15;66(16):8131-8. doi: 10.1158/0008-5472.CAN-06-1333. Cancer Res. 2006. PMID: 16912191

3

1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.

Ma Y, Yu WD, Hershberger PA, Flynn G, Kong RX, Trump DL, Johnson CS. Ma Y, et al. Among authors: yu wd. Mol Cancer Ther. 2008 Sep;7(9):3047-55. doi: 10.1158/1535-7163.MCT-08-0243. Mol Cancer Ther. 2008. PMID: 18790784 Free PMC article.

4

Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.

Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Light BW, et al. Among authors: yu wd. Cancer Res. 1997 Sep 1;57(17):3759-64. Cancer Res. 1997. PMID: 9288784

5

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL. Hershberger PA, et al. Among authors: yu wd. Clin Cancer Res. 2001 Apr;7(4):1043-51. Clin Cancer Res. 2001. PMID: 11309356

6

Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.

Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS. Bernardi RJ, et al. Among authors: yu wd. Clin Cancer Res. 2001 Dec;7(12):4164-73. Clin Cancer Res. 2001. PMID: 11751517

7

Anti-tumor activity of calcitriol: pre-clinical and clinical studies.

Trump DL, Hershberger PA, Bernardi RJ, Ahmed S, Muindi J, Fakih M, Yu WD, Johnson CS. Trump DL, et al. Among authors: yu wd. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):519-26. doi: 10.1016/j.jsbmb.2004.03.068. J Steroid Biochem Mol Biol. 2004. PMID: 15225831 Review.

8

Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.

Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL. Chung I, et al. Among authors: yu wd. Cancer Res. 2006 Sep 1;66(17):8565-73. doi: 10.1158/0008-5472.CAN-06-0905. Cancer Res. 2006. PMID: 16951169

9

In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.

Rassnick KM, Muindi JR, Johnson CS, Balkman CE, Ramnath N, Yu WD, Engler KL, Page RL, Trump DL. Rassnick KM, et al. Among authors: yu wd. Cancer Chemother Pharmacol. 2008 Oct;62(5):881-91. doi: 10.1007/s00280-008-0678-x. Epub 2008 Feb 2. Cancer Chemother Pharmacol. 2008. PMID: 18246349 Free PMC article. Clinical Trial.

10

1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.

Ma Y, Yu WD, Trump DL, Johnson CS. Ma Y, et al. Among authors: yu wd. Cancer. 2010 Jul 1;116(13):3294-303. doi: 10.1002/cncr.25059. Cancer. 2010. PMID: 20564622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters